Effects of Therapeutic Exercise in Patients With Fibromyalgia
CompletedNot applicableNCT04817605
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Fibromyalgia syndrome is characterized by chronic generalized musculoskeletal pain associated with fatigue, sleep disturbances and some biochemical markers. The European League Againts Rheumatism (EULAR) described an algorithm how to treat step by step these patients. The objective of this trial is to evaluate if therapeutic exercise is effective on fatigue, pain threshold, quality of life, quality of sleep, pain coping and biochemical and genetic markers. For this purpose, the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of fibromyalgia according to the American College of Rheumatology (ACR). Patients included one group receiving exercise therapy consisting of 3 treatment sessions a week over 10 weeks. The variables are measured at the beginning and end of treatment.
Study details
- Official title
- Effects of Therapeutic Exercise in Patients With Fibromyalgia
- Conditions
- Therapeutic Exercise
- Chronic Pain
- Interventions
- Sponsor
- Universidad de Zaragoza
- Start date
- 2021-03-10
- Primary completion
- 2022-06-10
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosed medically with Fibromyalgia * Diagnosed according to the American College of Rheumatology criteria * Agreement to attend to treatment sessions Exclusion Criteria: * Any kind of contraindications for physical activity * Other kind of diseases that could limit the intervention * Previous surgery last year * Medication modifications in the last 3 months
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04817605